Alpine Woods Capital Investors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Alpine Woods Capital Investors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-17,800	Closed	-$151K	–	497
2015 Q3	$151K	Hold	17,800	–	–	0.01%	458
2015 Q2	$269K	Sell	17,800 -200	-1%	-$2.89K	0.01%	399
2015 Q1	$288K	Hold	18,000	–	–	0.01%	391
2014 Q4	$321K	Buy	18,000 +6,000	+50%	+$74.8K	0.02%	372
2014 Q3	$120K	Hold	12,000	–	–	0.01%	444
2014 Q2	$187	Hold	12,000	–	–	﹤0.01%	423
2014 Q1	$223K	Buy	+12,000	New	+$240K	0.01%	405

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Alpine Woods Capital Investors's PETX Position: Q4 2015 in Review

Alpine Woods Capital Investors sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 17,800 shares — an estimated $151K sold.

Alpine Woods Capital Investors first reported a position in PETX in Q1 2014 and held it in 7 quarters. The position peaked at $321K in Q4 2014. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

Alpine Woods Capital Investors reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Alpine Woods Capital Investors sold 17,800 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $151K.
Alpine Woods Capital Investors first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Alpine Woods Capital Investors's Aratana Therapeutics, Inc. position peaked at $321K in Q4 2014.
98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2015, filed 10 Feb 2016.